LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Home・Stock List・Abeona Therapeutics Inc

Abeona Therapeutics Inc

Closed

4.2 0.48

Buy Sell

Overview

Share price change

24h

Current

Min

4.13

Max

4.23

Key metrics
By Trading Economics
P/E Sector Avg	7.179 77.256
Employees	136

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+377.33% upside

Dividends
By Dow Jones
Next Earnings	12 Nov 2025

Market Stats
By TradingEconomics
Market Cap	-66M 210M
Previous open	3.72
Previous close	4.2

Abeona Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Nov 2025, 21:06 UTC

Major Market Movers

JBS Down After Trump Calls for Probe into Meat-Packing Companies

7 Nov 2025, 22:36 UTC

Earnings

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 Nov 2025, 22:22 UTC

Earnings

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 Nov 2025, 22:03 UTC

Earnings

Constellation Software 3Q Rev $2.95B >CSU.T

7 Nov 2025, 22:03 UTC

Earnings

Constellation Software 3Q Net $210M >CSU.T

7 Nov 2025, 22:03 UTC

Earnings

Constellation Software 3Q EPS $9.89 >CSU.T

7 Nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 Nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 Nov 2025, 20:59 UTC

Earnings

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 Nov 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 Nov 2025, 20:22 UTC

Earnings

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 Nov 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 Nov 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 Nov 2025, 19:31 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 Nov 2025, 19:17 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 Nov 2025, 19:09 UTC

Earnings

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 Nov 2025, 19:08 UTC

Earnings

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 Nov 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 Nov 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 Nov 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 Nov 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 Nov 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 Nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

7 Nov 2025, 17:17 UTC

Acquisitions, Mergers, Takeovers

Satair Expects to Complete Purchase in Early 2026

7 Nov 2025, 17:17 UTC

Acquisitions, Mergers, Takeovers

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

7 Nov 2025, 17:15 UTC

Acquisitions, Mergers, Takeovers

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

7 Nov 2025, 17:09 UTC

Market Talk

PENN Is Falling Further Behind Competitors -- Market Talk

7 Nov 2025, 16:49 UTC

Market Talk

Losing ESPN Partnership Will Hurt PENN -- Market Talk

7 Nov 2025, 16:24 UTC

Market Talk

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

7 Nov 2025, 16:17 UTC

Market Talk

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

Peer Comparison

Price change

Abeona Therapeutics Inc Forecast

Price Target

By TipRanks

377.33% upside

12 Months Forecast

Average 20 USD 377.33%

High 20 USD

Low 20 USD

Based on 2 Wall Street analysts offering 12 month price targets forAbeona Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Abeona Therapeutics Inc - Dist in the past 3 months.

Financials

About Abeona Therapeutics Inc

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.